NEWARK, Del., June 24, 2020 /PRNewswire/ -- Today, the National Institute for Innovation in Manufacturing Biopharmacueticals (NIIMBL) announces that they have…
GAITHERSBURG, Md., June 29, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced it was…